Skip to content

Clinical efficacy and mechanical exploration of peripheral nerve selective excision and transfer combined with rehabilitation training in central upper limb spastic paralysis

Clinical efficacy and mechanical exploration of peripheral nerve selective excision and transfer combined with rehabilitation training in central upper limb spastic paralysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117564
Enrollment
Unknown
Registered
2026-01-26
Start date
2024-12-26
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central nervous system injury diseases, such as stroke, cerebral palsy, traumatic brain injury, spastic paralysis of the upper limbs during the recovery period of spinal cord injury patients

Interventions

Control group:Peripheral nerve balancing
Intervention group:Peripheral Nerve Balancing + Rehabilitative Train

Sponsors

Beijing Bo'ai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients over 12 years old with stroke, cerebral palsy (hemiplegia, triple limb palsy, quadriple limb palsy), traumatic brain injury, cerebral tumor, cerebrovascular accident and other central nervous system injuries with limb spasticity or central spastic palsy develop spasticity of the upper limbs after one year and the degree of spasticity is unchanged in the last 3 months; 2. Spasticity state is not significantly improved or relapsed by conservative treatments (physical therapy, occupational therapy, medication, botulinum toxin injections, etc.); 3. Modified Ashworth Scale (MAS) >= grade 2 without upper limb deformity.

Exclusion criteria

Exclusion criteria: 1. severe mental or cognitive impairment, unable to cooperate with the rehabilitation training; 2. serious primary disease or poor general physical condition; 3. combined with severe irreversible muscle contracture and bone deformity; 4. contraindications to surgery or anesthesia; 5. long term oral anti-spasticity drugs such as baclofen, carbamazepine, etc. have not been discontinued.

Design outcomes

Primary

MeasureTime frame
Surface electromyography;Modified Ashworth Scale;

Secondary

MeasureTime frame
Range of motion;Fugl-Meyer Upper Extremity Scale;Simple test for evaluating hand function;Modified Barthel Index;Self-rating Anxiety Scale;Self-rating Depression Scale;Motor Evoked Potential;Task-Based Functional Magnetic Resonance Imaging;Electroencephalogram;Pinch test;Grip strength test;Shallow sensory assessment;Deep Sensory Assessment;Manual muscle test;

Countries

China

Contacts

Public ContactLi Jun

Beijing Bo'ai Hospital

lijun2009crrc@163.com+86 10 87569087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026